Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase 1/2 3Phase NA 1Phase 3 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 1061Neoplasms 887Prostatic Neoplasms 513Lung Neoplasms 426Colorectal Neoplasms 360Motor Activity 226Head and Neck Neoplasms 195Uterine Cervical Neoplasms 194Carcinoma, Non-Small-Cell Lung 182Brain Neoplasms 176Pancreatic Neoplasms 162Ovarian Neoplasms 143Colonic Neoplasms 140Carcinoma, Hepatocellular 137Anxiety Disorders 125Rectal Neoplasms 119Hematologic Neoplasms 116Multiple Myeloma 109Stomach Neoplasms 105Neoplasm Metastasis 100Precursor Cell Lymphoblastic Leukemia-Lymphoma 97Melanoma 93Depression 93Pain 89Urinary Bladder Neoplasms 88Glioblastoma 87Endometrial Neoplasms 87Disease 85Lymphoma 84Sarcoma 78

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Adenocarcinoma, Mucinous × 1 year × Clear all
NCT05947838 2026-05-18

A Prospective Feasibility Study Using ctDNA to Tailor Neoadjuvant Chemotherapy for Patients With Colorectal or Appendiceal Adenocarcinoma

M.D. Anderson Cancer Center

Phase NA Recruiting
48 enrolled

Adenocarcinoma, Mucinous

Data powered by HemOnc (CC BY 4.0) Colophon âš¡